arrow
R

Raül Rigo-Bonnin

institut d'investigacio biomedica de bellvitge (idibell)
H指数:20
被引数:2,447

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Switching from etravirine to doravirine in people with HIV harbouring NNRTI resistance-associated mutations: the DorSwitch pilot study

替诺福韦酯转换为多替拉韦酯治疗携带NNRTI耐药相关突变的人类免疫缺陷病毒感染者的DorSwitch探索性研究

2026-09-040
PRE
Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study

优化肾移植受者中IR-Tac至LCP-Tac制剂的剂量转换:一项群体药代动力学模型研究

2025-09-190
OAAI
Optimising Meropenem and Piperacillin Dosing in Patients Undergoing Extracorporeal Membrane Oxygenation Without Renal Dysfunction (MEPIMEX)

优化无肾功能不全的体外膜肺氧合患者美罗培南和哌拉西林剂量(MEPIMEX)

2025-09-170
OAAI
Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study
2024-09-091
PRE
Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size

Vedolizumab和ART在最近的HIV-1感染中揭示了 α4β7在储层大小中的作用

2024-07-090
OA
Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial
2023-10-193
OAAI
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
2023-09-193
PRE